1-Star Price $130.95 5-Star Price $67.90 Economic Moat Wide Capital Allocation Standard Bulls Say, Bears Say Bulls Gilead markets several single-tablet regimens for HIV, and its next-generation products with better long-term safety profiles, led by Biktarvy, are boosting the company's market...
NewsProfileAnalyst Coverage5 Yr. FinancialsDividendsEarningsPrice HistoryEventsInsidersGilead Sciences Inc. News Finance News & Analysis Nov 3, 2024 7:16 PM EST Fed interest rate decision and election may roil stocks Trump, Harris, the Fed, and a bevy of earnings reports are on deck. PLTRAAPL...
Analyst Price Target is $86.85 ▼-2.97% Downside Potential This price target is based on 23 analysts offering 12 month price targets for Gilead Sciences in the last 3 months. The average price target is $86.85, with a high forecast of $105.00 and a low forecast of $69.00. The average ...
A high-level overview of Gilead Sciences, Inc. (GILD) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
11 hours ago Analysts revise Rivian stock price targets ahead of Q3 earnings Here’s what to expect in Rivian’s Nov. 7 earnings release. RIVNVWAGYAMZN Advanced Chart 1D 5D 3M 6M YTD 1Y 2Y 3Y 5Y 10Y chevron_right Frequency Daily
Discover real-time Gilead Sciences, Inc. Common Stock (GILD) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.
Galapagos climbs 5.4% after exercising co-promotion option with Gilead Dec. 15, 2017 at 3:17 a.m. ET by Sara Sjolin 5 things to know about biotech Denali Therapeutics and its $250 million IPO Dec. 11, 2017 at 7:55 a.m. ET by Emma Court European stocks slump as caution over...
Gilead buys more Arcus Biosciences stock, at a price above the record close Feb. 1, 2021 at 8:13 a.m. ETby Tomi Kilgore Gilead increases stake in Arcus Biosciences to 19.5% from 13% Feb. 1, 2021 at 8:04 a.m. ETby Tomi Kilgore ...
Silverhit its lowest price in around two months, also weighing on a fund designed to track the metal. The metal traded as cheap as $22.15 on Monday. That marks the worst level since Nov. 14, when it also hit $22.15. TheiShares Silver Trust (SLV)slipped more than 2% in morning trading...
109.35 +0.88% Mkt Cap 221.053B Industry Drug Manufacturers—General GILD Gilead Sciences, Inc. 89.51 +0.78% Mkt Cap 111.439B Industry Drug Manufacturers—GeneralStatistics: BIIB View More Valuation Measures Current Quarterly Annual As of 11/1/2024 Market Cap 25.32B Enterprise Value 30.28B ...